SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Ixia (XXIA) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 46/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — XXIA
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio3.30
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.42
Book Value / Share$0.00
Revenue / Share$5.95
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2007 |
$0.10 |
$174.12M |
$7.01M |
4% |
| 2008 |
$-0.24 |
$175.87M |
$-15.9M |
-9% |
| 2009 |
$-0.70 |
$177.99M |
$-44.2M |
-24.8% |
| 2010 |
$0.17 |
$276.82M |
$11.21M |
4% |
| 2011 |
$0.33 |
$308.36M |
$23.78M |
7.7% |
| 2012 |
$0.54 |
$413.43M |
$45.46M |
11% |
| 2013 |
$0.15 |
$467.26M |
$11.87M |
2.5% |
| 2014 |
$-0.54 |
$464.46M |
$-41.59M |
-9% |
| 2015 |
$0.07 |
$516.94M |
$5.95M |
1.2% |
| 2016 |
$-0.42 |
$484.85M |
$-33.91M |
-7% |
